LINCOLN Quarterly Results, Profit & Loss, Balance Sheet (LINCOLN)
LINCOLN quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Lincoln Pharmaceuticals Ltd reported sales of ₹191 Cr, operating profit of ₹24 Cr (OPM 12%) and net profit of ₹20 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
LINCOLN quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
147
168
154
163
166
187
177
191
Expenses
123
141
130
138
143
162
150
168
Operating Profit
24
27
24
25
24
25
27
24
OPM
16%
16%
15%
16%
14%
13%
15%
12%
Other Income
9
-7
15
7
15
-4
24
10
Interest
1
0
0
0
0
0
0
0
Depreciation
3
3
3
4
4
4
4
4
Profit before tax
29
16
35
29
35
17
48
29
Tax
28%
29%
22%
31%
18%
30%
24%
30%
Net Profit
21
12
28
20
29
12
36
20
EPS in Rs
10.37
5.78
13.82
9.98
14.28
5.81
18.09
10.2
LINCOLN profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
472
510
581
623
671
722
Expenses
376
421
480
522
573
623
Operating Profit
96
90
100
102
98
100
OPM
20%
18%
17%
16%
15%
14%
Other Income
10
22
34
22
33
45
Interest
1
2
1
2
1
1
Depreciation
8
9
11
13
14
15
Profit before tax
96
100
122
109
116
128
Tax
28%
27%
24%
25%
24%
-
Net Profit
69
73
93
82
88
97
EPS in Rs
34.63
36.4
46.58
41.11
43.88
48.38
Dividend Payout
4%
4%
4%
4%
4%
-
LINCOLN balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
20
20
20
20
20
Reserves
573
652
696
738
792
Borrowings
1
0
0
4
3
Other Liabilities
106
125
139
128
149
Total Liabilities
700
797
855
890
964
Fixed Assets
179
182
185
191
191
CWIP
3
4
3
5
7
Investments
139
174
209
209
245
Other Assets
379
437
458
486
522
Total Assets
700
797
855
890
964
LINCOLN cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
76
39
63
93
106
Cash from Investing Activity
-78
-37
-57
-79
-98
Cash from Financing Activity
-3
-4
-5
-6
0
Net Cash Flow
-4
-2
1
8
8
Free Cash Flow
31
26
24
74
82
CFO/OP
104%
77%
89%
117%
135%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit